Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giancarlo Castaman

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Current Opinion in Hematology|July 16, 2013
New development in von Willebrand diseaseGiancarlo Castaman
Thrombosis Research|April 13, 2016
Risk of thrombosis in cancer and the role of supportive care (transfusion, catheters, and growth factors)Giancarlo Castaman
Blood Transfusion = Trasfusione Del Sangue|July 8, 2017
The role of recombinant activated factor VII in the haematological management of elective orthopaedic surgery in haemophilia A patients with inhibitorsGiancarlo Castaman
Blood Transfusion = Trasfusione Del Sangue|December 25, 2008
Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disordersGiancarlo Castaman
Mediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand DiseaseGiancarlo Castaman
Thrombosis Research|August 22, 2020
How I treat von Willebrand diseaseGiancarlo Castaman
Expert Review of Hematology|June 19, 2018
The benefits of prophylaxis in patients with hemophilia BGiancarlo Castaman
Journal of Clinical Medicine|December 11, 2022
Hemostatic Abnormalities in Gaucher Disease: Mechanisms and Clinical ImplicationsSilvia Linari, Giancarlo Castaman
Therapeutics and Clinical Risk Management|June 18, 2020
Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical EvidenceSilvia Linari, Giancarlo Castaman
Seminars in Hematology|January 22, 2005
Treatment of von Willebrand diseaseFrancesco Rodeghiero, Giancarlo Castaman
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Current Opinion in Hematology|July 16, 2013
New development in von Willebrand diseaseGiancarlo Castaman
Thrombosis Research|April 13, 2016
Risk of thrombosis in cancer and the role of supportive care (transfusion, catheters, and growth factors)Giancarlo Castaman
Blood Transfusion = Trasfusione Del Sangue|July 8, 2017
The role of recombinant activated factor VII in the haematological management of elective orthopaedic surgery in haemophilia A patients with inhibitorsGiancarlo Castaman
Blood Transfusion = Trasfusione Del Sangue|December 25, 2008
Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disordersGiancarlo Castaman
Mediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand DiseaseGiancarlo Castaman
Thrombosis Research|August 22, 2020
How I treat von Willebrand diseaseGiancarlo Castaman
Expert Review of Hematology|June 19, 2018
The benefits of prophylaxis in patients with hemophilia BGiancarlo Castaman
Journal of Clinical Medicine|December 11, 2022
Hemostatic Abnormalities in Gaucher Disease: Mechanisms and Clinical ImplicationsSilvia Linari, Giancarlo Castaman
Therapeutics and Clinical Risk Management|June 18, 2020
Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical EvidenceSilvia Linari, Giancarlo Castaman
Seminars in Hematology|January 22, 2005
Treatment of von Willebrand diseaseFrancesco Rodeghiero, Giancarlo Castaman
Pageof 22